Lara Rizzotto

1.5k total citations
33 papers, 944 citations indexed

About

Lara Rizzotto is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Lara Rizzotto has authored 33 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Genetics and 8 papers in Immunology. Recurrent topics in Lara Rizzotto's work include Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (7 papers) and MicroRNA in disease regulation (5 papers). Lara Rizzotto is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (7 papers) and MicroRNA in disease regulation (5 papers). Lara Rizzotto collaborates with scholars based in Italy, United States and Switzerland. Lara Rizzotto's co-authors include Carlo M. Croce, Veronica Balatti, Alexey Palamarchuk, Yuri Pekarsky, Giovanni Nigita, Thomas J. Kipps, Laura Z. Rassenti, Dario Veneziano, Chang‐Gong Liu and Harvey I. Pass and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Lara Rizzotto

33 papers receiving 938 citations

Peers

Countries citing papers authored by Lara Rizzotto

Since Specialization

Citations

This map shows the geographic impact of Lara Rizzotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Rizzotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Rizzotto more than expected).

Fields of papers citing papers by Lara Rizzotto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Rizzotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Rizzotto. The network helps show where Lara Rizzotto may publish in the future.

Co-authorship network of co-authors of Lara Rizzotto

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Rizzotto. A scholar is included among the top collaborators of Lara Rizzotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Rizzotto. Lara Rizzotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferation 2025 ·Journal of Experimental & Clinical Cancer Research ·(unknown), (unknown), Lara Rizzotto, Anna Tessari, (unknown), Rosa Visone, Liwen Zhang, (unknown), Lino Tessarollo, Joseph M. Amann, David P. Carbone, Alessia Lodi, Amer Ahmed, Ruggiero Gorgoglione, Giuseppe Fiermonte, (unknown), Dario Palmieri, (unknown), Vincenzo Coppola	1
2	Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma 2021 ·The Journal of Experimental Medicine ·Roberto Vendramin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Panagiotis Karras, (unknown), Francesca M. Bosisio, (unknown), Jan Rozman, Ivan Gladwyn‐Ng, Lara Rizzotto, Erik Dassi, Stefania Millevoi, Oliver Bechter, Jean‐Christophe Marine, Eleonora Leucci	28
3	Establishment, characterization and imaging of a first platinum-resistant penile cancer patient derived xenograft in nude mice: An eUROGEN project 2020 ·European Urology Open Science ·Maarten Albersen, (unknown), (unknown), Uroš Milenković, Herlinde Dumez, Gert De Meerleer, Steven Joniau, Wouter Everaerts, Igor Tsaur, (unknown), Uwe Himmelreich, Christopher Cawthorne, Christophe M. Deroose, Lien Spans, Isabelle Vanden Bempt, Eleonora Leucci, Anne‐Sophie Van Rompuy, Lara Rizzotto	1
4	Targeting BTK through microRNA in chronic lymphocytic leukemia 2016 ·Blood ·Arianna Bottoni, Lara Rizzotto, (unknown), Chaomei Liu, Lisa L. Smith, Rose Mantel, Sean D. Reiff, Dalia El‐Gamal, Karilyn Larkin, Amy J. Johnson, Rosa Lapalombella, Amy Lehman, William Plunkett, John C. Byrd, James S. Blachly, Jennifer A. Woyach, Deepa Sampath	22
5	Role of Histone Deacetylase-Mediated Gene Silencing in Chronic Lymphocytic Leukemia Progression 2016 ·Blood ·Lara Rizzotto, Arianna Bottoni, (unknown), Chaomei Liu, Pearlly S. Yan, Hatice Gülçin Özer, Rosa Lapalombella, Jennifer A. Woyach, Christopher C. Oakes, James S. Blachly, Deepa Sampath	1
6	HDAC Inhibition Induces microRNA-182 Which Targets Rad51 Protein and Impairs Homologous Recombination Repair to Sensitize Cells to the Double Strand Break Inducing Nucleoside Analog, Sapacitabine in AML 2015 ·Blood ·(unknown), (unknown), Brett Ewald, Chaomei Liu, Lara Rizzotto, Melanie Sulda, Dimitrios Papaioannou, Ramiro Garzon, William Plunkett, Deepa Sampath	1
7	HDAC Inhibitor AR-42 Decreases CD44 Expression and Sensitizes Myeloma Cells to Lenalidomide 2014 ·Blood ·(unknown), Douglas W. Sborov, Alessandro Canella, Zhongfa Liu, Jessica Consiglio, Wenjun Ni, Emily Smith, Lara Rizzotto, Yvonne A. Efebera, Don M. Benson, Luciano Cascione, (unknown), John C. Byrd, Michael R. Grever, Craig C. Hofmeister, Flavia Pichiorri	2
8	miR Deregulation in CLL 2013 ·Advances in experimental medicine and biology ·Veronica Balatti, (unknown), Lara Rizzotto, Carlo M. Croce	22
9	The HIV-1 Tat Protein Induces the Activation of CD8+ T Cells and Affects In Vivo the Magnitude and Kinetics of Antiviral Responses 2013 ·PLoS ONE ·Francesco Nicoli, (unknown), (unknown), Lara Rizzotto, Eleonora Gallerani, Federica Destro, Aurelio Cafaro, Peggy Marconi, Antonella Caputo, Barbara Ensoli, Riccardo Gavioli	26
10	Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 2013 ·Experimental Hematology ·Rossana Maffei, Stefania Fiorcari, Jenny Bulgarelli, Lara Rizzotto, Silvia Martinelli, Gian Matteo Rigolin, (unknown), Ilaria Castelli, Goretta Bonacorsi, (unknown), Francesco Forconi, Davide Rossi, Luca Laurenti, Giuseppe A. Palumbo, Daniele Vallisa, Antonio Cuneo, Gianluca Gaïdano, Mario Luppi, Roberto Marasca	25
11	Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 2013 ·Oncotarget ·Gian Matteo Rigolin, Elena Saccenti, Lara Rizzotto, Manuela Ferracin, (unknown), Luca Formigaro, (unknown), Maurizio Cavallari, Enrico Lista, (unknown), (unknown), Maria Ciccone, Francesco Cavazzini, Laura Lupini, Cristian Bassi, Barbara Zagatti, Massimo Negrini, Antonio Cuneo	7
12	Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with “normal” FISH: correlations with clinicobiologic parameters 2012 ·Blood ·Gian Matteo Rigolin, (unknown), (unknown), Luca Formigaro, Lara Rizzotto, Elisa Tammiso, Elena Saccenti, Antonella Bardi, Francesco Cavazzini, Maria Ciccone, Ilaria Nichele, Giovanni Pizzolo, Francesco Zaja, Renato Fanin, Piero Galieni, (unknown), (unknown), (unknown), Massimo Negrini, Antonio Cuneo	50
13	Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 2011 ·Haematologica ·Alessio Branchini, Lara Rizzotto, Giuliano Mariani, Mariasanta Napolitano, Mario Lapecorella, Muriel Giansily‐Blaizot, (unknown), Alessandro Canella, Mirko Pinotti, (unknown)	20
14	Clonal evolution including 14q32/IGHtranslocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 2011 ·Leukemia & lymphoma ·Francesco Cavazzini, Lara Rizzotto, (unknown), (unknown), (unknown), (unknown), Maria Ciccone, Elena Saccenti, Melissa Dabusti, (unknown), Antonella Bardi, Elisa Tammiso, Antonio Cuneo, Gian Matteo Rigolin	16
15	Employment of Oligodeoxynucleotide plus Interleukin‐2 Improves Cytogenetic Analysis in Splenic Marginal Zone Lymphoma 2011 ·BioMed Research International ·Antonella Bardi, Francesco Cavazzini, Gian Matteo Rigolin, Elisa Tammiso, (unknown), (unknown), Luca Formigaro, (unknown), (unknown), (unknown), Lara Rizzotto, (unknown), Fiorella D’Auria, Pellegrino Musto, Antonio Cuneo	6
16	Circulating endothelial cells in patients with chronic lymphocytic leukemia 2010 ·Cancer ·Gian Matteo Rigolin, Rossana Maffei, Lara Rizzotto, Maria Ciccone, (unknown), (unknown), (unknown), Francesco Cavazzini, Roberto Marasca, Antonio Cuneo	24
17	MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 2010 ·Molecular Cancer ·Manuela Ferracin, Barbara Zagatti, Lara Rizzotto, Francesco Cavazzini, Angelo Veronese, Maria Ciccone, Elena Saccenti, Laura Lupini, Andrea Grilli, Cristiano De Angeli, Massimo Negrini, Antonio Cuneo	88
18	INTRACELLULAR EVALUATION OF ER TARGETING ELUCIDATES A MILD FORM OF INHERITED COAGULATION DEFICIENCY 2007 ·Journal of Thrombosis and Haemostasis ·Lara Rizzotto, Mirko Pinotti, Paolo Pinton, Rosario Rizzuto, Francesco Bernardi	1
19	Intracellular Evaluation of ER Targeting Elucidates a Mild Form of Inherited Coagulation Deficiency 2006 ·Molecular Medicine ·Lara Rizzotto, Mirko Pinotti, Paolo Pinton, Rosario Rizzuto, Francesco Bernardi	6
20	Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII 2006 ·Journal of Thrombosis and Haemostasis ·Mirko Pinotti, Lara Rizzotto, Paolo Pinton, P. Ferraresi, Ampaiwan Chuansumrit, Pimlak Charoenkwan, Giovanna Marchetti, Rosario Rizzuto, Giuliano Mariani, Francesco Bernardi	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact